Cobimetinib Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with cobimetinib
I
- Ibrance (palbociclib)
- Iclusig (ponatinib)
- Idacio (adalimumab)
- Ide-cet (acetaminophen / butalbital / caffeine)
- idelalisib
- Idenal (aspirin / butalbital / caffeine)
- Ilaris (canakinumab)
- Ilosone (erythromycin)
- imatinib
- Imlygic (talimogene laherparepvec)
- Imovax Rabies (rabies vaccine, human diploid cell)
- Imuran (azathioprine)
- Incivek (telaprevir)
- indinavir
- Infanrix (DTaP) (diphtheria and tetanus toxoids / pertussis, acellular)
- Inflectra (infliximab)
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- Inrebic (fedratinib)
- Intelence (etravirine)
- interferon beta-1a
- interferon beta-1b
- Intestinex (lactobacillus acidophilus)
- Invirase (saquinavir)
- Ipol (poliovirus vaccine, inactivated)
- isavuconazonium
- Isocet (acetaminophen / butalbital / caffeine)
- IsonaRif (isoniazid / rifampin)
- isoniazid
- isoniazid / pyrazinamide / rifampin
- isoniazid / rifampin
- Isoptin (verapamil)
- Isoptin IV (verapamil)
- Isoptin SR (verapamil)
- istradefylline
- Isturisa (osilodrostat)
- itraconazole
- ivacaftor
- ivacaftor / lumacaftor
- ivacaftor / tezacaftor
- ivosidenib
- Ixchiq (chikungunya vaccine, live (cvx 317))
- Ixiaro (japanese enceph vacc sa14-14-2, inactivated)
- Ixifi (infliximab)
More about cobimetinib
- cobimetinib consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.